The purpose of the national program is to provide useful knowledge about the corona pandemic, both now and in the case of future pandemics, to improve preventions, diagnostics and treatments of viral disease, provide a clearer real-time overview of the pandemic, integrate data across technologies and research domains, and create better predictive models.
Program Directors: Olli Kallioniemi, Karolinska Institutet and Mia Phillipson, Uppsala University (also members of SciLifeLab Management Group)
Program Coordinators: Disa L. Hammarlöf, KTH Royal Institute of Technology, and Alice Sollazzo, Uppsala University (also members of SciLifeLab Operations Office).
With support from KAW, the SciLifeLab National COVID-19 Research Program has been extended until 2022. We welcome input and ideas from the SciLifeLab community on how to best continue the program. Please submit your feedback to:
Launched through an open call for proposals, the program contains 67 projects within nine research areas, studying COVID-19 at the molecular, cellular, patient, population and environmental level.
To enable synergies, the projects will be connected to each other, leverage the SciLifeLab infrastructure, and contribute to open data as well as the national COVID-19 data portal. The projects are funded with a total of 50 MSEK from Knut and Alice Wallenberg Foundation. In addition, the SciLifeLab board has decided to allocate 12 MSEK of national SciLifeLab funding, for coordinating the program and connecting it with the SciLifeLab infrastructure. The national funding has now been utilized to, among other things, fund a call for needs within the program.
Each research area has been appointed a scientific lead and coordinator, who promote collaboration and data sharing within the area, and help to form links within the entire program, and to SciLifeLab’s infrastructure, data management support and the COVID-19 program management.
In March 2020, SciLifeLab launched a national call for researchers nationwide, to create a comprehensive program to combat the coronavirus pandemic. A total of 285 proposals were submitted, with applicants ranging from several Swedish universities and hospitals, and other organizations both in Sweden and abroad. The SciLifeLab management group and experts in the field reviewed all proposals and approved 67 for funding.
The projects will be funded with a total of 50 MSEK from Knut and Alice Wallenberg Foundation. Furthermore, the SciLifeLab board has allocated 12 MSEK for coordination of the program and connecting it with the SciLifeLab infrastructure, to further strengthen the effects of the initiative.
Besides scientific impact, the evaluation criteria considered were relevance and impact on tackling the COVID-19 pandemic, opportunities created by the SciLifeLab community, possibility to form synergies and collaborations, commitment to open data and real-time updates of progress.
Proportions of each research area.
To further promote a strong and collaborative research environment within the COVID-19 program, and ensure that the participants have the resources required to conduct their COVID-19 related research at full speed, a program-specific call was launched in June 2020. The focus of the call was infrastructure needs, and conditions that need to be met in order to form capabilities between research areas and SciLifeLab facilities.
The call mainly addressed the most urgent and critical needs, to get the projects up-and-running. Need inventories were formulated by scientific leads, coordinators and PIs representing five of the nine research areas, and after a review by the program management and SciLifeLab Infrastructure Director, national funding was decided to support the following needs:
The funding will amount to a total of 4,4 MSEK, of which 1 MSEK will be allocated to data management support for the program.
A second call, focused on more long-term infrastructure needs and possible new capabilities, was launched in August, allowing more time for discussions of solutions and possibilities between research areas and SciLifeLab platforms and collaborators. 6.4 MSEK national funding was decided to support:
This document describes the background of SciLifeLab:s national COVID-19 program. It outlines program milestones, sets the framework for how the research program is structured and how it operates, through connections to the infrastructure, Data Centre and other SciLifeLab functions. Follow-up reports will describe the results of the program.
Funding through the SciLifeLab National COVID-19 Research Program should be acknowledged as This study was supported by grants to Science for Life Laboratory from the Knut and Alice Wallenberg Foundation (2020.0182).
Project financial reporting
Please find below the deadlines for sending the financial reports and requisition regarding KAW-grants for COVID-19 to Marika Kokk, KTH. For this purpose, please use the KAW-requisition template and enclose documentation for the costs, such as extracts from the general ledger.
All costs regarding 2020 must be submitted by email by 31st of January 2021.
All costs regarding 2021 must be submitted by email by 31st of January 2022.
Please note that costs that have not been reported by the second, final deadline for this project, cannot be reimbursed.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.